This page lists all pharmaceutical reports related to the field of Infectious Diseases. The reports include market research reports and pipeline analyses.
Displaying 101 - 150 of 170 results
- The World Market for Biosimilars and the Potential for US Follow-on Biologics
- The World Antibacterial Treatments Market 2010-2024
- Influenza Vaccine Market Outlook 2010-2020
- Global Pharmaceutical Biotech Market 2010-2025
- What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and Other Vaccine Targets in the 2010-2020 Pipeline
- The Market for Prescription Dermatological Drugs
- The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
- The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
- The Future of Orphan Disease Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
- The Future of Global Vaccines - Market Forecasts to 2016, Stockpile Analysis, Competitive Benchmarking and Pipeline Analysis
- The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
- Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
- Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
- Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
- Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
- Telaprevir - Blazing a path to the HCV market
- H1N1 Swine Flu Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
- The Worldwide Over-the-Counter (OTC) Drug Market
- Cystic Fibrosis - Drug Pipeline Analysis and Market Forecasts to 2015
- Hepatitis B Vaccines - Pipeline Analysis and Market Forecasts to 2015
- Ulcerative Colitis - Drug Pipeline Analysis and Market Forecasts to 2015
- World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)
- Global Vaccines Market 2010-2025
- Automated Microbial Testing Markets
- Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
- Meningitis Preventive Vaccines - Pipeline Analysis and Market Forecasts to 2017
- Anti-Infective Drugs Markets
- Hepatitis Therapeutics Market to 2016 - Strong Hepatitis-C Pipeline and Cost Effective Treatments will Drive the Global Hepatitis Market
- Influenza Vaccines - Pipeline Assessment and Market Forecasts to 2017
- In Vitro Diagnostics (Immunochemistry and Infectious Immunology) Global Market Briefing to 2016
- Genetic Testing Global Market Briefing to 2016
- European Vaccine Markets
- US Pharmaceutical Market Outlook 2011-2021
- Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
- Pharmaceutical Industry - 2010 Yearbook - Therapeutic Market Landscape, Key Pipeline Drugs, Top Pharma Companies and Key Mergers and Acquisitions
- Infectious Diseases Vaccine Market Overview
- Molecular Diagnostics in Infectious Disease Testing
- Hospital Acquired Bacterial Infections Market to 2016 - Increasing Antibiotic Resistance and Increasing Population of Critically Ill Patients To Drive Growth
- In-vitro and Companion Diagnostics Industry - 2010 Yearbook
- The Future of In Vitro and In Vivo Diagnostic Integration
- Infectious Diseases Vaccine Market Overview
- Pharmaceutical Key Trends 2011 – Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
- Pharmaceutical Key Trends 2011 – Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
- Pharmaceutical Key Trends 2011 – Biosimilar Market Overview: Biosimilar uptake set to accelerate
- R&D Trends: Hepatitis C
- Epidemiology: Hepatitis C - Hepatitis C virus will remain a prevalent bloodborne disease in the seven major markets, primarily transmitted through injection drug use
- R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapy
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Travel Vaccines Market to 2017 - Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure